InvestorsHub Logo
Followers 840
Posts 120476
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 172

Wednesday, 05/12/2021 4:19:58 PM

Wednesday, May 12, 2021 4:19:58 PM

Post# of 254
EOLS 1Q21 sales=$12.2M—3/31/21_pro_forma*_cash=$140M:

https://investors.evolus.com/news-releases/news-release-details/evolus-reports-first-quarter-2021-results-and-provides-business

1Q21 Jeuveau sales of $12.2M were sharply down from $20.6M in 4Q21 due to seasonality and to the absence of sales during the first half of 1Q21, prior to the litigation settlement with Medytox/Allergan.

EOLS has not issued sales guidance, but the above PR says that 2Q21 Jeuveau sales are “on track for” an annualized rate of $100M.

*Includes $117.6M raised since 3/31/21: $25.5 million from Daewoong in April 2021 (#msg-162731989) and $92.1 million net proceeds from the 4/21/21 public offering (#msg-163353769).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EOLS News